Effect of intravitreal dexamethasone implant in treatment-naive and previously-treated patients with diabetic macular edema.

Eleni NikolopoulouRiccardo Sacconi Lorusso Massimo Eliana Costanzo Mariacristina ParravanoLuisa Micelli FerrariTommaso Micelli FerrariFrancesca Amoroso

Published in: European journal of ophthalmology (2022)

intravitreal dexamethasone implant is effective in the treatment of diabetic center-involving macular edema and was associated with significant improvements in BCVA and CMT at 2 months after injection. After a single dexamethasone implant injection, FAZ area and retinal vascular density does not show significant variations in both naive and non-naive DME patients subgroups.

Keyphrases

diabetic retinopathy
low dose
high dose
optical coherence tomography
end stage renal disease
newly diagnosed
soft tissue
vascular endothelial growth factor
ejection fraction
type diabetes
chronic kidney disease
combination therapy
patient reported
optic nerve